N-n-propyl-N-n-butyl-beta-dopamine

RN given refers to parent cpd; dopamine D2 receptor agonist

Also Known As:

N-PBDA; N-n-propyl-N-n-butyl-beta-(3,4-dihydroxyphenyl)ethylamine; N-n-propyl-N-n-butyl-beta-dopamine hydrochloride; N-n-propyl-N-n-butyl-beta-dopamine hydroiodide; propylbutyldopamine; 1,2-benzenediol, 4-((2-butylpropylamino)ethyl)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Catecholamines: 15682
    - Dopamine: 23033
      - N-n-propyl-N-n-butyl-beta-dopamine: 2
  - Biogenic Amines: 992
    - Biogenic Monoamines: 29
      - Dopamine: 23033
        N-n-propyl-N-n-butyl-beta-dopamine: 2
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Catecholamines: 15682
        Dopamine: 23033
        N-n-propyl-N-n-butyl-beta-dopamine: 2

Related Diseases

1.	Heart Failure 04/01/1983 - "Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure."
2.	Essential Hypertension 03/01/1984 - "The effects of propylbutyldopamine ( PBDA ), an analog of dopamine lacking significant vasoconstrictor effects, were examined in seven patients with essential hypertension. "

Related Drugs and Biologics

1.	Vasoconstrictor Agents
2.	Dopamine (Intropin)